Calamos Advisors
PEPL

Calamos Advisors’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Calamos Advisors’s Portfolio PEPL Stock Details PEPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-700,000
Closed -$7.15M – 1245
2022
Q4 		$7.15M Hold
700,000
– – 0.03% 568
2022
Q3 		$6.99M Buy
+700,000
New +$6.95M 0.03% 592

Other funds holding PEPL

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Calamos Advisors's PEPL Position: Q1 2023 in Review

Calamos Advisors sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 700,000 shares — an estimated $7.15M sold.

Calamos Advisors first reported a position in PEPL in Q3 2022 and held it in 2 quarters. The position peaked at $7.15M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Calamos Advisors reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Calamos Advisors sold 700,000 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $7.15M.
  • Calamos Advisors first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q3 2022 and held it in 2 quarters.
  • Calamos Advisors's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $7.15M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.